Ahmed Mushood, Zulfiqar Eeshal, Shafiq Aimen, Shahzad Maryam, Hashmi Tallal Mushtaq, Ahmed Raheel, Rana Jamal S, Sidney Stephen, Greene Stephen J, Mentz Robert J, Fudim Marat, Fonarow Gregg C
Rawalpindi Medical University, Rawalpindi, Pakistan.
Dow University of Health Sciences, Karachi, Pakistan.
JACC Adv. 2025 Jun 17;4(7):101882. doi: 10.1016/j.jacadv.2025.101882.
The prevalence of type 2 diabetes mellitus (T2DM) has increased in the United States, contributing significantly to morbidity and mortality.
This study analyzes trends in T2DM-related mortality focusing on demographic and regional disparities.
The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database was utilized to extract death certificate data for adults aged 25 and older from 1999 to 2023. Age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated. Temporal trends were assessed by calculating the annual percent change using Joinpoint regression analysis.
From 1999 to 2023, a total of 2,031,626 deaths were attributed to T2DM in the United States. The AAMR more than doubled from 21.54 per 100,000 in 1999 to 53.95 per 100,000 in 2023 with a pronounced increase between 2018 and 2021 (AAMR: 62.7 in 2021, annual percent change: 16.06%; 95% CI: 11.84-19.66). Males had considerably higher AAMR than females (68.82 vs 42.48 in 2023). Among racial and ethnic groups, Hispanic or Latino populations had the highest AAMR in 2023 (69.69), followed by non-Hispanic Black or African American (65.45), non-Hispanic other populations (53.7), and non-Hispanic White group (49.98). The Western region of the United States showed the highest AAMR (78.29), and rural areas consistently had higher mortality rates compared to urban areas (69.88 vs 55.32 in 2020). From 1999 to 2023, cardiovascular disease accounted for 626,706 deaths among adults with T2DM.
T2DM-related mortality has increased substantially over the time in the United States, with a peak observed between 2018 and 2021, emphasizing the need for targeted interventions.
2型糖尿病(T2DM)在美国的患病率有所上升,对发病率和死亡率有显著影响。
本研究分析T2DM相关死亡率的趋势,重点关注人口统计学和地区差异。
利用疾病控制与预防中心的广泛在线流行病学研究数据库,提取1999年至2023年25岁及以上成年人的死亡证明数据。计算每10万人的年龄调整死亡率(AAMR)。通过使用Joinpoint回归分析计算年度百分比变化来评估时间趋势。
1999年至2023年,美国共有2031626例死亡归因于T2DM。AAMR从1999年的每10万人21.54例增加了一倍多,到2023年达到每10万人53.95例,在2018年至2021年期间有显著增加(2021年AAMR:62.7,年度百分比变化:16.06%;95%CI:11.84-19.66)。男性的AAMR显著高于女性(2023年为68.82对42.48)。在种族和族裔群体中,西班牙裔或拉丁裔人群在2023年的AAMR最高(69.69),其次是非西班牙裔黑人或非裔美国人(65.45)、非西班牙裔其他人群(53.7)和非西班牙裔白人组(49.98)。美国西部地区的AAMR最高(78.29),农村地区的死亡率一直高于城市地区(2020年为69.88对55.32)。1999年至2023年,心血管疾病占T2DM成年患者死亡人数的626706例。
在美国,T2DM相关死亡率随时间大幅增加,在2018年至2021年期间达到峰值,强调了针对性干预措施的必要性。